PeterS2325 Mar 2021 11:32
Thanks for your post earlier. The final point, on patience, is a pertinent one.
I think sometimes investors become a little blinkered by RNS and timelines. Yes I think it’s fair to say that CF has perhaps been naive in setting timelines that don’t come to fruition. But equally, we know he’s so busy actually growing the business, that he’s more than forgiven for not being totally investor focused 100% of the time. What he’s achieved so far has surely earned our patience as PIs (take note, longinvestments, or ship out).
I, and am sure many others too, feel like we’ve backed a winner here. So many investments are binary ‘either this product or idea succeeds or it fails’, but with Orph, we have at least 5 potential ideas tjat could multibag, let alone any selling off of non core assets, dividends, or the truly exciting prospect of Orph Pharma.
Sit tight, enjoy the ride, let’s leave the graphs and the RNS alone for a bit and remember why we invested in this potentially massive company.
Cheers, BC